| ACEI | angiotensin-converting enzyme inhibitor |
| AGTR2 | angiotensin receptor type 2 |
| BK | bradykinin |
| BSA | bovine serum albumin |
| CA4P | combretastatin A4 phosphate |
| CO | carbon monoxide |
| DMXAA | 5,6-dimethylxanthenone-4-acetic acid |
| DOX | doxorubicin |
| EC | endothelial cell |
| ECM | extracellular matrix |
| EGF | epidermal growth factor |
| EGFR | epidermal growth factor receptor |
| EPR | enhanced permeability and retention |
| Et-A/B | endothelin-A/B |
| FGF | fibroblast growth factor |
| FLK1/KDR | vascular endothelial growth factor receptor 2 |
| FLT1 | vascular endothelial growth factor receptor 1 |
| GFNC | gadofullerene nanocrystal |
| HDZ | hydralazine |
| HGF | hepatocyte growth factor |
| HIF | hypoxia-inducible factor |
| HO | heme oxygenase |
| 131I | iodine-131 |
| ICAM-1 | intercellular adhesion molecule-1 |
| IFP | interstitial fluid pressure |
| IL | interleukin |
| iNOS | inducible nitric oxide synthase |
| LLV | leukolike vector |
| MMP | matrix metalloproteinase |
| NO | nitric oxide |
| NF-κB | nuclear factor kappa-B |
| PDGF | platelet-derived growth factor |
| PDGFR | platelet-derived growth factor receptor |
| PEG | polyethylene glycol |
| PLGF | placenta growth factor |
| RGD | arginylglycylaspartic acid |
| RNAi | RNA interference |
| SDF-1 | stromal cell-derived factor 1 |
| sFLT1 | soluble vascular endothelial growth factor receptor 1 |
| shRNA | short hairpin RNA |
| siRNA | small interfering RNA |
| tetrac | tetraiodothyroacetic acid |
| TGF-β | transforming growth factor-β |
| TIMP | tissue inhibitor of metalloproteinase |
| TME | tumor microenvironment |
| TNF-α | tumor necrosis factor-α |
| t-PA | tissue plasminogen activator |
| VDA | vascular disrupting agent |
| VEGF | vascular endothelial growth factor |
| VEGFR | vascular endothelial growth factor receptor |
| VPF | vascular permeability factor |